Also trades as: 7476.T (JPX) · $vol 3M

$14.00

+0.00 (+0.00%)

OTC · Healthcare · Medical - Distribution · Tech Score Sell · Power 47 · $997.7M mcap · 56M float · 0.0001% daily turnover

Revenue

$103.8B +8.6% ▲

5Y CAGR: +8.1%

Gross Profit

$31.3B +7.1% ▲

5Y CAGR: +7.4%

Operating Income

$11.6B +11.1% ▲

5Y CAGR: +6.3%

Net Income

$8.2B +9.7% ▲

5Y CAGR: +6.6%

EPS (Diluted)

$114.87 +11.0% ▲

5Y CAGR: -6.4%

EBITDA

$13.6B +7.8% ▲

5Y CAGR: +6.9%

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$81.6B	$87.0B	$91.4B	$95.5B	$103.8B
YoY Growth	+15.9%	+6.6%	+5.1%	+4.5%	+8.6%
Cost of Revenue	$55.7B	$61.4B	$63.0B	$66.3B	$72.4B
Gross Profit	$25.9B	$25.5B	$28.5B	$29.2B	$31.3B
Gross Margin	31.8%	29.4%	31.1%	30.6%	30.2%
R&D Expenses	$28M	$17M	$25M	$0	$0
SG&A Expenses	$16.0B	$16.2B	$17.1B	$18.8B	$0
Operating Expenses	$16.0B	$16.2B	$17.1B	$18.8B	$19.7B
Operating Income	$9.9B	$9.3B	$11.4B	$10.4B	$11.6B
Operating Margin	12.1%	10.7%	12.5%	10.9%	11.2%
Interest Expense	$10M	$3M	$3M	$5M	$8M
Income Before Tax	$8.9B	$10.5B	$11.7B	$10.8B	$11.8B
Tax Expense	$3.0B	$3.3B	$3.6B	$3.3B	$3.6B
Net Income	$6.0B	$7.2B	$8.1B	$7.5B	$8.2B
Net Margin	7.3%	8.3%	8.9%	7.9%	7.9%
EPS (Diluted)	$80.03	$96.21	$109.30	$103.50	$114.87
EBITDA	$10.7B	$12.2B	$13.3B	$12.7B	$13.6B
Shares Outstanding	37M	37M	74M	72M	72M

Line Item	FY2024 Q2	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1
Revenue	$24.5B	$170M	$189M	$178M	$174M	$27.8B	$31.7B	$29.8B
Cost of Revenue	$17.0B	$118M	$133M	$123M	$121M	$19.3B	$22.4B	$20.6B
Gross Profit	$7.4B	$52M	$57M	$55M	$53M	$8.5B	$9.3B	$9.2B
Gross Margin	30.5%	30.4%	29.9%	30.7%	30.4%	30.6%	29.3%	30.9%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$4.9B	$32M	$35M	$33M	$34M	$5.1B	$5.9B	$5.2B
Operating Expenses	$4.9B	$32M	$35M	$33M	$34M	$5.1B	$5.9B	$5.2B
Operating Income	$2.5B	$20M	$21M	$22M	$20M	$3.4B	$3.4B	$4.0B
Operating Margin	10.3%	11.7%	11.3%	12.2%	11.2%	12.3%	10.8%	13.3%
Interest Expense	$578K	$9K	$34K	$69K	$61K	$10M	$8M	$11M
Income Before Tax	$2.7B	$20M	$21M	$23M	$20M	$3.5B	$3.5B	$4.1B
Tax Expense	$861M	$6M	$6M	$7M	$6M	$1.1B	$1.0B	$1.3B
Net Income	$1.9B	$14M	$15M	$16M	$14M	$2.4B	$2.5B	$2.8B
Net Margin	7.6%	8.0%	8.0%	8.9%	7.9%	8.6%	7.8%	9.5%
EPS (Diluted)	$26.00	$0.19	$0.21	$0.22	$0.19	$33.40	$35.15	$40.36
EBITDA	$3.2B	$23M	$24M	$26M	$23M	$4.0B	$3.9B	$4.4B
Shares Outstanding	72M	72M	72M	72M	72M	72M	71M	71M

IUSDF OTC